Results 201 to 210 of about 72,745 (313)

Development of VFP-Type Left Ventricular Assist Device

open access: diamond, 2023
Ryo KASAMATSU, Atsushi SHIRAI
openalex   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger   +15 more
wiley   +1 more source

Left Ventricular Assist Device Followed by Heart Transplantation

open access: yesArquivos Brasileiros de Cardiologia, 2015
Bruno Biselli   +5 more
doaj   +1 more source

Left Ventricular Assist Device Destination Therapy: A Journey to Home and Beyond. [PDF]

open access: yesJACC Case Rep
Munir MZ   +3 more
europepmc   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh   +18 more
wiley   +1 more source

Percutaneous management and outcomes of outflow graft obstruction in patients with left ventricular assist device: A single-center experience. [PDF]

open access: yesJHLT Open
Wu Y   +10 more
europepmc   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García   +17 more
wiley   +1 more source

Chronic kidney disease following left ventricular assist device implantation: contemporary insights and future perspectives. [PDF]

open access: yesHeart Fail Rev
Alvarez-Echeverry I   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy